Gemini-Genomics: Putting the Power of Bioinformatics in Every Sri Lankan Researcher’s Hands

The Problem Nobody Talks About

There’s a quiet frustration that lives in genomics labs across South Asia, and it rarely makes it into research papers or conference talks. A biologist spends weeks preparing samples, runs an expensive sequencing experiment, and finally gets the data back-only to stare at a wall of cryptic terminal output, dense tables of numbers, and assembly logs that look like they were written for a computer, not a human being.

The science worked. The machine did its job. But now what?

In well-funded institutions abroad, there’s usually a bioinformatician down the hall who can make sense of it all. In a university lab in Colombo or Peradeniya, that person often doesn’t exist. And hiring external consultants or cloud-based analysis platforms costs money that most research budgets here simply don’t have.

This is the gap I wanted to close when I built Gemini-Genomics.

What Gemini-Genomics Actually Does

At its core, Gemini-Genomics is an AI-powered assistant built specifically to read and interpret genomic data-the kind of raw, messy, technical output that sequencing machines and assembly tools produce. A researcher can paste in a FASTA file, drop in a QUAST assembly report, or upload a quality log, and within seconds receive a clear, structured explanation of what the data means, what went wrong, and what to do next.

It’s not a replacement for deep bioinformatics expertise. It’s more like having a knowledgeable colleague who can quickly triage your data, flag the most important issues, and explain everything in plain language-so you can get back to doing science instead of debugging shell scripts.

Why This Problem Is Harder Than It Looks

Genomic assembly data is notoriously difficult to work with, even for experienced researchers. When a sequencer finishes its run, it doesn’t hand you a clean, finished genome. It hands you millions of short fragments — reads — that need to be computationally stitched back together into longer contiguous sequences called contigs and scaffolds. This process is called de novo assembly, and it almost never goes perfectly.

Assembly errors come in many forms. Some regions of the genome are misjoined sequences that don’t actually belong together get forced together by the algorithm. Others are left unassembled entirely, showing up as gaps or unaligned scaffolds in the output. The N50 metric, a standard measure of assembly quality, tells you whether your assembly is fragmented into thousands of tiny pieces or resolved into long, reliable stretches.

A skilled bioinformatician can look at a QUAST report and immediately spot when something is wrong: a low N50 paired with a high misassembly count is a red flag. An unusual number of interchromosomal rearrangements suggests the assembler was confused by repetitive regions. Unaligned length greater than a certain threshold hints at contamination or a reference mismatch.

The trouble is that reading these signals takes training that most wet-lab biologists never received. And the files themselves can be enormous hundreds of thousands of lines making manual inspection impractical.

The Technical Choices Behind the Tool

I built Gemini-Genomics on a deliberately lightweight stack. The backend runs on FastAPI, a modern Python framework that’s fast to develop with and efficient in production. The frontend is a minimal web interface clean, accessible, built to stay out of the way of the actual work.

The analytical engine is Google Gemini 2.5, accessed through Google AI Studio and Vertex AI. Choosing Gemini wasn’t just a default decision it was a deliberate one, driven by a specific capability that matters enormously for this use case: its massive context window.

Most large language models struggle with long documents. When you feed them a 50,000-token QUAST report, they either truncate the input or lose coherence halfway through, missing connections between metrics that appear far apart in the file. Gemini 2.5 can hold the entire report in context at once, maintaining consistency from the first line to the last. For genomic data analysis, this isn’t a nice-to-have — it’s essential.

+------------------+      +-----------------+      +-----------------------+
|  Researcher UI   | ---> |  Python Backend | ---> | Google Gemini 2.5 API |
| (FASTA / QUAST)  |      |   (FastAPI)     |      | (Vertex AI / Studio)  |
+------------------+      +-----------------+      +-----------------------+

The Prompt Engineering Layer

Getting a large language model to reliably produce scientifically accurate outputs not plausible-sounding but actually correct required serious attention to the system prompt architecture.

The model is instructed to behave as an expert computational biologist and bioinformatician. But more importantly, it’s given a structured analytical framework: specific rules for interpreting metric combinations, explicit instructions to flag anomalies with exact coordinates or contig references pulled directly from the input, and a mandate to skip conversational filler entirely and focus on quantitative findings.

For example, the model is taught to recognize that a low N50 value is not inherently alarming in isolation context matters. A low N50 in a complex polyploid plant genome assembled from short reads is expected. The same N50 in a bacterial genome assembled from long reads is a serious warning sign. The prompt engineering captures these distinctions and instructs the model to reason accordingly.

This is the part of the project that required the most iteration. Getting the outputs to feel genuinely expert rather than generic AI summaries dressed up in scientific language took dozens of refinement cycles.

Three Things It Does Well

1. Spotting Assembly Errors Before They Propagate

Bad assemblies lead to bad downstream analyses. If your genome has misassembled regions and you don’t catch them early, every variant call, gene annotation, and comparative analysis built on top of it is compromised. Gemini-Genomics scans assembly reports and immediately highlights the specific issues: interchromosomal misassemblies, structural inversions, unaligned scaffolds, locally misassembled regions. It points to exact locations in the assembly rather than offering vague warnings.

2. Translating Numbers Into Narratives

A QUAST report might tell you that your assembly has 1,247 contigs, an N50 of 48,312 bp, 23 misassemblies, and 4.2% unaligned length. Gemini-Genomics doesn’t just echo those numbers back — it tells you what they mean together. Is this a good assembly for your organism? What does the misassembly count suggest about your sequencing library? Should you attempt a second assembly with different parameters? These are the questions researchers actually need answered.

3. Making Bioinformatics Accessible Without Dumbing It Down

This was perhaps the hardest balance to strike. The tool is designed to be useful for a plant geneticist who has never opened a terminal, but it shouldn’t patronize the molecular biologist who understands the underlying biology and just needs the computational layer explained. The outputs are structured to be immediately useful to both clear enough for non-programmers, rigorous enough for domain experts.

What This Means for Research in Sri Lanka

Sri Lanka has genuine strengths in biological research. The country’s agricultural sector drives significant investment in plant genetics and crop improvement. Endemic biodiversity — from its highland tea cultivars to its coastal mangrove ecosystems represents scientifically valuable genomic resources that remain understudied.

What has historically limited the translation of that biological potential into published, impactful research is infrastructure. Not laboratory infrastructure sequencing is increasingly affordable and accessible. The bottleneck is analytical infrastructure: the computational expertise and the time it takes to move from raw data to insight.

Gemini-Genomics directly addresses that bottleneck. A researcher working on a new rice variety at a state university doesn’t need to wait weeks for an external collaborator to analyze their assembly quality report. They can get a rigorous first-pass analysis in minutes, identify whether their assembly is trustworthy enough to proceed, and focus their limited resources on the experiments that matter.

What’s Coming Next

The current version of Gemini-Genomics is a working prototype, and an honest one it does what it promises, but there’s a clear roadmap for where it needs to go.

The most significant planned addition is Retrieval-Augmented Generation (RAG). Rather than relying purely on the model’s general scientific training, the next version will connect to curated local databases: genomic references for Sri Lankan crop varieties, endemic species assemblies, and regionally relevant pathogen genomes. When a researcher uploads data from a local Oryza sativa cultivar or a Sri Lankan rubber tree, the system will be able to compare it against locally relevant references rather than generic global databases.

This matters because biology is contextual. A misassembly pattern that looks routine in a temperate crop genome might be significant in a tropical variety with a different repeat landscape. Local reference data makes the difference between generic analysis and genuinely useful analysis.

Beyond RAG, there are plans to expand the supported file types to include raw VCF variant files, RNA-seq alignment summaries, and pangenome comparison outputs broadening the tool’s utility across more stages of the genomic research pipeline.

A Closing Thought

Genomics shouldn’t be a field where insights are locked behind the salary of a bioinformatics consultant or the postal code of a well-funded institution. The raw data is increasingly cheap to generate. The knowledge to interpret it should be just as accessible.

Gemini-Genomics is one small attempt to push in that direction — to take a powerful, general-purpose AI technology and focus it precisely on a real problem that real researchers in this part of the world are dealing with right now. It’s not a finished product. It’s a starting point, and a proof that these tools are buildable, deployable, and useful without a team of engineers or a Silicon Valley budget.

The biology is here. The data is here. The tools should be here too.